These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 14688041)

  • 1. ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital.
    Tumbarello M; Citton R; Spanu T; Sanguinetti M; Romano L; Fadda G; Cauda R
    J Antimicrob Chemother; 2004 Feb; 53(2):277-82. PubMed ID: 14688041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonality of Providencia stuartii isolates involved in outbreak that occurred in a burn unit.
    Saida NB; Thabet L; Messadi A; Bouselmi K; Turki A; Boukadida J
    Burns; 2008 Sep; 34(6):829-34. PubMed ID: 18241997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
    Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
    Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial dissemination of Providencia stuartii isolates carrying bla OXA-48, bla PER-1, bla CMY-4 and qnrA6 in a Tunisian hospital.
    Mnif B; Ktari S; Chaari A; Medhioub F; Rhimi F; Bouaziz M; Hammami A
    J Antimicrob Chemother; 2013 Feb; 68(2):329-32. PubMed ID: 23014719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant Providencia stuartii expressing extended-spectrum beta-lactamase PER-1, originating in Kosovo.
    Poirel L; Bruderer T; Frei R; Bernabeu S; Graber P; Nordmann P
    J Antimicrob Chemother; 2008 Jun; 61(6):1392-3. PubMed ID: 18334492
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Perea EJ; Pérez-Cano R; Hernández JR; Pascual A
    Clin Infect Dis; 2006 Jan; 42(1):37-45. PubMed ID: 16323089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spread of CTX-M-15 positive Providencia spp. causing urinary tract infections at the University Hospital Split in Croatia.
    Barl P; Bedenić B; Sardelić S; Uzunović S; Vraneš J; Plečko V
    Med Glas (Zenica); 2012 Aug; 9(2):317-24. PubMed ID: 22926370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
    Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
    J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
    Ben-Ami R; Rodríguez-Baño J; Arslan H; Pitout JD; Quentin C; Calbo ES; Azap OK; Arpin C; Pascual A; Livermore DM; Garau J; Carmeli Y
    Clin Infect Dis; 2009 Sep; 49(5):682-90. PubMed ID: 19622043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of PEr 1 extended-spectrum β-lactamase among nosocomial providencia stuartii isolates in Tunisia.
    Lahlaoui H; Ben Moussa M
    Tunis Med; 2014 Apr; 92(4):258-61. PubMed ID: 25224421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates.
    Al-Zarouni M; Senok A; Rashid F; Al-Jesmi SM; Panigrahi D
    Med Princ Pract; 2008; 17(1):32-6. PubMed ID: 18059098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
    Mosqueda-Gómez JL; Montaño-Loza A; Rolón AL; Cervantes C; Bobadilla-del-Valle JM; Silva-Sánchez J; Garza-Ramos U; Villasís-Keever A; Galindo-Fraga A; Palacios GM; Ponce-de-León A; Sifuentes-Osornio J
    Int J Infect Dis; 2008 Nov; 12(6):653-9. PubMed ID: 18511321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
    J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
    Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of plasmid-mediated quinolone resistance-qnrA1 and blaVEB-1 gene in a Providencia stuartii strain.
    Nazik H; Bektöre B; Öngen B; Özyurt M; Baylan O; Haznedaroğlu T
    New Microbiol; 2011 Apr; 34(2):225-8. PubMed ID: 21617836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR; Saxena AK; Al-Ghamdi AM
    Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution and dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997-2003).
    DiPersio JR; Deshpande LM; Biedenbach DJ; Toleman MA; Walsh TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jan; 51(1):1-7. PubMed ID: 15629222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.